Medacta Surpasses Market Growth with 9.7% Revenue Increase

Medacta Group SA reported above-market revenue growth of 9.7% in constant currency and a robust adjusted EBITDA margin of 27.8% in H1 2026.

The company recorded group revenue of Euro 368 million, a rise of 9.7% in constant currency and of 7.0% in Euros against an exceptionally strong comparable base.

The growth was delivered across all business lines and geographies, with the largest contributions coming from Asia Pacific and EMEA, which both grew in double-digits at respectively, 13.1% and 10.0% in constant currency.